Open AccessTwo are better than one on progression through MET mechanism for EGFR+ NSCLC patients
Author(s) -
Waleed Kian,
Laila C. Roisman,
Nir Peled
Publication year - 2018
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 41
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr.2018.12.01
Subject(s) - medicine , epidermal growth factor receptor , lung cancer , t790m , mechanism (biology) , cancer research , tyrosine kinase , egfr inhibitors , cancer , oncology , bioinformatics , receptor , biology , gefitinib , philosophy , epistemology